nodes	percent_of_prediction	percent_of_DWPC	metapath
Cevimeline—CYP2D6—Parkinson's disease	0.86	1	CbGaD
Cevimeline—CHRM1—GPCR downstream signaling—GRM4—Parkinson's disease	0.000134	0.000955	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—GRM4—Parkinson's disease	0.000133	0.000952	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—TALDO1—Parkinson's disease	0.000133	0.000948	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—OMD—Parkinson's disease	0.000133	0.000948	CbGpPWpGaD
Cevimeline—CHRM1—GPCR ligand binding—DRD3—Parkinson's disease	0.000131	0.00094	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—DRD3—Parkinson's disease	0.000131	0.000937	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—GPX1—Parkinson's disease	0.000131	0.000936	CbGpPWpGaD
Cevimeline—CYP2D6—Biological oxidations—COMT—Parkinson's disease	0.00013	0.00093	CbGpPWpGaD
Cevimeline—CYP2D6—Biological oxidations—GSTP1—Parkinson's disease	0.000129	0.000925	CbGpPWpGaD
Cevimeline—CYP2D6—Biological oxidations—MAOA—Parkinson's disease	0.000129	0.000923	CbGpPWpGaD
Cevimeline—CYP2D6—Metapathway biotransformation—COMT—Parkinson's disease	0.000128	0.000917	CbGpPWpGaD
Cevimeline—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.000128	0.000913	CbGpPWpGaD
Cevimeline—CYP2D6—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000128	0.000912	CbGpPWpGaD
Cevimeline—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.000127	0.00091	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—VPS35—Parkinson's disease	0.000127	0.00091	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—VPS35—Parkinson's disease	0.000127	0.000907	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—PENK—Parkinson's disease	0.000127	0.000905	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—PENK—Parkinson's disease	0.000126	0.000903	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—NDUFB11—Parkinson's disease	0.000126	0.000899	CbGpPWpGaD
Cevimeline—CHRM1—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.000125	0.000894	CbGpPWpGaD
Cevimeline—CHRM3—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.000125	0.000891	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—GRM4—Parkinson's disease	0.000121	0.000867	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—GRM4—Parkinson's disease	0.000121	0.000865	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—MTHFR—Parkinson's disease	0.000121	0.000864	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—GCH1—Parkinson's disease	0.00012	0.000857	CbGpPWpGaD
Cevimeline—CHRM1—GPCR ligand binding—HTR7—Parkinson's disease	0.000119	0.00085	CbGpPWpGaD
Cevimeline—CHRM1—GPCR ligand binding—DRD2—Parkinson's disease	0.000119	0.00085	CbGpPWpGaD
Cevimeline—CYP2D6—Biological oxidations—GSTM1—Parkinson's disease	0.000119	0.00085	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—DRD2—Parkinson's disease	0.000118	0.000847	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—HTR7—Parkinson's disease	0.000118	0.000847	CbGpPWpGaD
Cevimeline—CYP2D6—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000117	0.000838	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—PDYN—Parkinson's disease	0.000116	0.000828	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—PDYN—Parkinson's disease	0.000115	0.000825	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—PENK—Parkinson's disease	0.000115	0.000822	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—PENK—Parkinson's disease	0.000115	0.00082	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—APOE—Parkinson's disease	0.000112	0.000804	CbGpPWpGaD
Cevimeline—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	0.000112	0.000802	CbGpPWpGaD
Cevimeline—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000111	0.000791	CbGpPWpGaD
Cevimeline—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.000109	0.000782	CbGpPWpGaD
Cevimeline—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.000109	0.000779	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—GRM5—Parkinson's disease	0.000108	0.00077	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—GRM5—Parkinson's disease	0.000107	0.000767	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—FBP1—Parkinson's disease	0.000107	0.000764	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—GBA—Parkinson's disease	0.000107	0.000764	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—DBH—Parkinson's disease	0.000107	0.000764	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—DGKQ—Parkinson's disease	0.000105	0.000754	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—GPR37—Parkinson's disease	0.000105	0.000754	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—PDYN—Parkinson's disease	0.000105	0.000752	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—DGKQ—Parkinson's disease	0.000105	0.000751	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—GPR37—Parkinson's disease	0.000105	0.000751	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—PDYN—Parkinson's disease	0.000105	0.00075	CbGpPWpGaD
Cevimeline—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	0.000103	0.000733	CbGpPWpGaD
Cevimeline—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000101	0.000723	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—GRM5—Parkinson's disease	9.77e-05	0.000699	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—GRM5—Parkinson's disease	9.74e-05	0.000697	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—PPP1R1B—Parkinson's disease	9.64e-05	0.000689	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—PPP1R1B—Parkinson's disease	9.61e-05	0.000687	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—INS—Parkinson's disease	9.61e-05	0.000687	CbGpPWpGaD
Cevimeline—CHRM1—GPCR ligand binding—EDN1—Parkinson's disease	9.52e-05	0.000681	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—EDN1—Parkinson's disease	9.49e-05	0.000679	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—ADORA2A—Parkinson's disease	9.15e-05	0.000655	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—ADORA2A—Parkinson's disease	9.12e-05	0.000653	CbGpPWpGaD
Cevimeline—CYP3A4—Biological oxidations—COMT—Parkinson's disease	8.5e-05	0.000608	CbGpPWpGaD
Cevimeline—CHRM1—Circadian rythm related genes—MAPK8—Parkinson's disease	8.47e-05	0.000606	CbGpPWpGaD
Cevimeline—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	8.46e-05	0.000605	CbGpPWpGaD
Cevimeline—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	8.44e-05	0.000603	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—MCCC1—Parkinson's disease	8.43e-05	0.000603	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—ND3—Parkinson's disease	8.43e-05	0.000603	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—RIT2—Parkinson's disease	8.42e-05	0.000603	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—RIT2—Parkinson's disease	8.4e-05	0.000601	CbGpPWpGaD
Cevimeline—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	8.38e-05	0.000599	CbGpPWpGaD
Cevimeline—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	8.34e-05	0.000597	CbGpPWpGaD
Cevimeline—CHRM1—GPCR ligand binding—HTR2A—Parkinson's disease	8.33e-05	0.000595	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—ADORA2A—Parkinson's disease	8.31e-05	0.000594	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—HTR2A—Parkinson's disease	8.3e-05	0.000594	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—ADORA2A—Parkinson's disease	8.28e-05	0.000593	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—GRK5—Parkinson's disease	7.99e-05	0.000571	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—GRK5—Parkinson's disease	7.96e-05	0.000569	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—HTR1A—Parkinson's disease	7.94e-05	0.000568	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—OMD—Parkinson's disease	7.92e-05	0.000567	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—TALDO1—Parkinson's disease	7.92e-05	0.000567	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—HTR1A—Parkinson's disease	7.92e-05	0.000566	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—DDC—Parkinson's disease	7.84e-05	0.000561	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—TAC1—Parkinson's disease	7.82e-05	0.000559	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—TAC1—Parkinson's disease	7.8e-05	0.000558	CbGpPWpGaD
Cevimeline—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	7.77e-05	0.000556	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—DRD1—Parkinson's disease	7.67e-05	0.000549	CbGpPWpGaD
Cevimeline—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	7.66e-05	0.000548	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—DRD1—Parkinson's disease	7.64e-05	0.000547	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—NDUFB11—Parkinson's disease	7.51e-05	0.000537	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—DRD3—Parkinson's disease	7.43e-05	0.000531	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—DRD3—Parkinson's disease	7.4e-05	0.00053	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—GSTA4—Parkinson's disease	7.4e-05	0.00053	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—HTR1A—Parkinson's disease	7.21e-05	0.000516	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—HTR1A—Parkinson's disease	7.19e-05	0.000514	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—GCH1—Parkinson's disease	7.17e-05	0.000513	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—GRM4—Parkinson's disease	7.16e-05	0.000512	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—GRM4—Parkinson's disease	7.14e-05	0.000511	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—TAC1—Parkinson's disease	7.1e-05	0.000508	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—TAC1—Parkinson's disease	7.08e-05	0.000506	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—DRD1—Parkinson's disease	6.96e-05	0.000498	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—DRD1—Parkinson's disease	6.94e-05	0.000497	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—ADRBK1—Parkinson's disease	6.94e-05	0.000496	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—ADRBK1—Parkinson's disease	6.91e-05	0.000495	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—PENK—Parkinson's disease	6.79e-05	0.000486	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—MAG—Parkinson's disease	6.79e-05	0.000486	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—MAG—Parkinson's disease	6.77e-05	0.000484	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—PENK—Parkinson's disease	6.77e-05	0.000484	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—DRD3—Parkinson's disease	6.74e-05	0.000482	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—DRD3—Parkinson's disease	6.72e-05	0.000481	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—HTR7—Parkinson's disease	6.72e-05	0.00048	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—DRD2—Parkinson's disease	6.72e-05	0.00048	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—HTR7—Parkinson's disease	6.7e-05	0.000479	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—DRD2—Parkinson's disease	6.7e-05	0.000479	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—PLA2G6—Parkinson's disease	6.67e-05	0.000477	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—MAOB—Parkinson's disease	6.6e-05	0.000472	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—FBP1—Parkinson's disease	6.39e-05	0.000457	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—DBH—Parkinson's disease	6.39e-05	0.000457	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—GBA—Parkinson's disease	6.39e-05	0.000457	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—ADRBK1—Parkinson's disease	6.3e-05	0.000451	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—ADRBK1—Parkinson's disease	6.28e-05	0.000449	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—PDYN—Parkinson's disease	6.21e-05	0.000444	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—PDYN—Parkinson's disease	6.19e-05	0.000443	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—HTR7—Parkinson's disease	6.1e-05	0.000436	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—DRD2—Parkinson's disease	6.1e-05	0.000436	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—DRD2—Parkinson's disease	6.08e-05	0.000435	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—HTR7—Parkinson's disease	6.08e-05	0.000435	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—GFAP—Parkinson's disease	5.84e-05	0.000418	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—GFAP—Parkinson's disease	5.82e-05	0.000416	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—GRM5—Parkinson's disease	5.77e-05	0.000413	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—GRM5—Parkinson's disease	5.76e-05	0.000412	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—ND3—Parkinson's disease	5.51e-05	0.000394	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—MCCC1—Parkinson's disease	5.51e-05	0.000394	CbGpPWpGaD
Cevimeline—CHRM1—Circadian rythm related genes—IL6—Parkinson's disease	5.41e-05	0.000387	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—EDN1—Parkinson's disease	5.38e-05	0.000385	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—EDN1—Parkinson's disease	5.36e-05	0.000383	CbGpPWpGaD
Cevimeline—FMO1—forebrain—Parkinson's disease	5.22e-05	0.129	CbGeAlD
Cevimeline—CYP3A4—Metabolism—TALDO1—Parkinson's disease	5.18e-05	0.000371	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—OMD—Parkinson's disease	5.18e-05	0.000371	CbGpPWpGaD
Cevimeline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	5.12e-05	0.000366	CbGpPWpGaD
Cevimeline—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	5.11e-05	0.000365	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—FGF20—Parkinson's disease	5.06e-05	0.000362	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—FGF20—Parkinson's disease	5.05e-05	0.000361	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	4.91e-05	0.000351	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—ADORA2A—Parkinson's disease	4.91e-05	0.000351	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—CYP2D6—Parkinson's disease	4.9e-05	0.000351	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—ADORA2A—Parkinson's disease	4.89e-05	0.00035	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—EDN1—Parkinson's disease	4.88e-05	0.000349	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—EDN1—Parkinson's disease	4.87e-05	0.000348	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—CTGF—Parkinson's disease	4.81e-05	0.000344	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—HTR2A—Parkinson's disease	4.7e-05	0.000337	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—HTR2A—Parkinson's disease	4.69e-05	0.000335	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—DDC—Parkinson's disease	4.69e-05	0.000335	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—GCH1—Parkinson's disease	4.68e-05	0.000335	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—INSR—Parkinson's disease	4.53e-05	0.000324	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—INSR—Parkinson's disease	4.52e-05	0.000323	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—CYP2E1—Parkinson's disease	4.49e-05	0.000321	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—NQO1—Parkinson's disease	4.44e-05	0.000317	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—GSTA4—Parkinson's disease	4.43e-05	0.000317	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—TH—Parkinson's disease	4.37e-05	0.000313	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—FGB—Parkinson's disease	4.28e-05	0.000306	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—HTR2A—Parkinson's disease	4.27e-05	0.000306	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—FGB—Parkinson's disease	4.27e-05	0.000305	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—HTR1A—Parkinson's disease	4.26e-05	0.000305	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—HTR2A—Parkinson's disease	4.26e-05	0.000305	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—HTR1A—Parkinson's disease	4.25e-05	0.000304	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—CYCS—Parkinson's disease	4.2e-05	0.0003	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—TAC1—Parkinson's disease	4.2e-05	0.0003	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—TAC1—Parkinson's disease	4.18e-05	0.000299	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—GBA—Parkinson's disease	4.18e-05	0.000299	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—FBP1—Parkinson's disease	4.18e-05	0.000299	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—DBH—Parkinson's disease	4.18e-05	0.000299	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—DRD1—Parkinson's disease	4.11e-05	0.000294	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—DRD1—Parkinson's disease	4.1e-05	0.000293	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	3.99e-05	0.000285	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—DRD3—Parkinson's disease	3.98e-05	0.000285	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—DRD3—Parkinson's disease	3.97e-05	0.000284	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—MAOB—Parkinson's disease	3.95e-05	0.000282	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—ADRBK1—Parkinson's disease	3.72e-05	0.000266	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—COMT—Parkinson's disease	3.72e-05	0.000266	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—ADRBK1—Parkinson's disease	3.71e-05	0.000265	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—GSTP1—Parkinson's disease	3.7e-05	0.000265	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—MAOA—Parkinson's disease	3.69e-05	0.000264	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—HMOX1—Parkinson's disease	3.65e-05	0.000261	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—DRD2—Parkinson's disease	3.6e-05	0.000258	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—HTR7—Parkinson's disease	3.6e-05	0.000258	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—DRD2—Parkinson's disease	3.59e-05	0.000257	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—HTR7—Parkinson's disease	3.59e-05	0.000257	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—ABCB1—Parkinson's disease	3.5e-05	0.00025	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—GSTM1—Parkinson's disease	3.4e-05	0.000243	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—GPX1—Parkinson's disease	3.26e-05	0.000233	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—DDC—Parkinson's disease	3.06e-05	0.000219	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—IGF2—Parkinson's disease	3.02e-05	0.000216	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—IGF2—Parkinson's disease	3.01e-05	0.000215	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—MTHFR—Parkinson's disease	3e-05	0.000215	CbGpPWpGaD
Cevimeline—FMO1—head—Parkinson's disease	2.99e-05	0.0738	CbGeAlD
Cevimeline—CHRM1—Signaling Pathways—IGF1R—Parkinson's disease	2.92e-05	0.000209	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—IGF1R—Parkinson's disease	2.91e-05	0.000208	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—GSTA4—Parkinson's disease	2.89e-05	0.000207	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—EDN1—Parkinson's disease	2.88e-05	0.000206	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—CTGF—Parkinson's disease	2.88e-05	0.000206	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—EDN1—Parkinson's disease	2.88e-05	0.000206	CbGpPWpGaD
Cevimeline—FMO1—nervous system—Parkinson's disease	2.83e-05	0.07	CbGeAlD
Cevimeline—CHRM3—Metabolism—APOE—Parkinson's disease	2.8e-05	0.0002	CbGpPWpGaD
Cevimeline—FMO1—central nervous system—Parkinson's disease	2.73e-05	0.0674	CbGeAlD
Cevimeline—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	2.68e-05	0.000192	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—NQO1—Parkinson's disease	2.65e-05	0.00019	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—NGF—Parkinson's disease	2.65e-05	0.00019	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—NGF—Parkinson's disease	2.64e-05	0.000189	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—TH—Parkinson's disease	2.61e-05	0.000187	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	2.61e-05	0.000186	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—MAOB—Parkinson's disease	2.58e-05	0.000185	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—HTR2A—Parkinson's disease	2.52e-05	0.000181	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—HTR2A—Parkinson's disease	2.52e-05	0.00018	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—CYCS—Parkinson's disease	2.51e-05	0.000179	CbGpPWpGaD
Cevimeline—CHRM1—forebrain—Parkinson's disease	2.4e-05	0.0592	CbGeAlD
Cevimeline—CHRM3—Metabolism—INS—Parkinson's disease	2.39e-05	0.000171	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—APOE—Parkinson's disease	2.35e-05	0.000168	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—APOE—Parkinson's disease	2.34e-05	0.000167	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—COMT—Parkinson's disease	2.22e-05	0.000159	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—GSTP1—Parkinson's disease	2.21e-05	0.000158	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—MAOA—Parkinson's disease	2.21e-05	0.000158	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—HMOX1—Parkinson's disease	2.18e-05	0.000156	CbGpPWpGaD
Cevimeline—FMO1—brain—Parkinson's disease	2.17e-05	0.0535	CbGeAlD
Cevimeline—CHRM3—forebrain—Parkinson's disease	2.14e-05	0.053	CbGeAlD
Cevimeline—CYP2D6—hindbrain—Parkinson's disease	2.1e-05	0.0518	CbGeAlD
Cevimeline—CYP2D6—Metabolism—ABCB1—Parkinson's disease	2.09e-05	0.00015	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—GSTM1—Parkinson's disease	2.03e-05	0.000145	CbGpPWpGaD
Cevimeline—CHRM1—cardiovascular system—Parkinson's disease	2.03e-05	0.05	CbGeAlD
Cevimeline—CHRM1—Signaling Pathways—INS—Parkinson's disease	2e-05	0.000143	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—INS—Parkinson's disease	2e-05	0.000143	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—GPX1—Parkinson's disease	1.95e-05	0.000139	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	1.92e-05	0.000137	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—CTGF—Parkinson's disease	1.88e-05	0.000135	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—MTHFR—Parkinson's disease	1.8e-05	0.000128	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	1.75e-05	0.000125	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—NQO1—Parkinson's disease	1.73e-05	0.000124	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—TH—Parkinson's disease	1.71e-05	0.000122	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—APOE—Parkinson's disease	1.67e-05	0.00012	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—CYCS—Parkinson's disease	1.64e-05	0.000117	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CASP3—Parkinson's disease	1.49e-05	0.000107	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CASP3—Parkinson's disease	1.49e-05	0.000106	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—IL6—Parkinson's disease	1.48e-05	0.000106	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—IL6—Parkinson's disease	1.48e-05	0.000106	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—COMT—Parkinson's disease	1.45e-05	0.000104	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—GSTP1—Parkinson's disease	1.45e-05	0.000103	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—MAOA—Parkinson's disease	1.44e-05	0.000103	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—INS—Parkinson's disease	1.43e-05	0.000102	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—HMOX1—Parkinson's disease	1.43e-05	0.000102	CbGpPWpGaD
Cevimeline—CHRM1—head—Parkinson's disease	1.37e-05	0.0339	CbGeAlD
Cevimeline—CHRM1—Signaling Pathways—MAPK8—Parkinson's disease	1.37e-05	9.81e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—ABCB1—Parkinson's disease	1.37e-05	9.79e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—MAPK8—Parkinson's disease	1.37e-05	9.78e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—GSTM1—Parkinson's disease	1.33e-05	9.51e-05	CbGpPWpGaD
Cevimeline—CHRM1—nervous system—Parkinson's disease	1.3e-05	0.0321	CbGeAlD
Cevimeline—CYP3A4—Metabolism—GPX1—Parkinson's disease	1.27e-05	9.1e-05	CbGpPWpGaD
Cevimeline—CHRM1—central nervous system—Parkinson's disease	1.25e-05	0.0309	CbGeAlD
Cevimeline—CHRM3—head—Parkinson's disease	1.23e-05	0.0303	CbGeAlD
Cevimeline—CYP2D6—brainstem—Parkinson's disease	1.2e-05	0.0297	CbGeAlD
Cevimeline—CYP3A4—Metabolism—MTHFR—Parkinson's disease	1.17e-05	8.4e-05	CbGpPWpGaD
Cevimeline—CHRM3—nervous system—Parkinson's disease	1.16e-05	0.0287	CbGeAlD
Cevimeline—CYP2D6—forebrain—Parkinson's disease	1.16e-05	0.0286	CbGeAlD
Cevimeline—CHRM3—central nervous system—Parkinson's disease	1.12e-05	0.0277	CbGeAlD
Cevimeline—CYP3A4—Metabolism—APOE—Parkinson's disease	1.09e-05	7.82e-05	CbGpPWpGaD
Cevimeline—CHRM1—brain—Parkinson's disease	9.94e-06	0.0246	CbGeAlD
Cevimeline—CYP3A4—Metabolism—INS—Parkinson's disease	9.34e-06	6.68e-05	CbGpPWpGaD
Cevimeline—CHRM3—brain—Parkinson's disease	8.9e-06	0.022	CbGeAlD
Cevimeline—CHRM1—Signaling Pathways—IL6—Parkinson's disease	8.76e-06	6.26e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—IL6—Parkinson's disease	8.73e-06	6.24e-05	CbGpPWpGaD
Cevimeline—CYP2D6—head—Parkinson's disease	6.64e-06	0.0164	CbGeAlD
Cevimeline—CYP3A4—nervous system—Parkinson's disease	6.4e-06	0.0158	CbGeAlD
Cevimeline—CYP2D6—nervous system—Parkinson's disease	6.29e-06	0.0155	CbGeAlD
Cevimeline—CYP3A4—central nervous system—Parkinson's disease	6.16e-06	0.0152	CbGeAlD
Cevimeline—CYP2D6—central nervous system—Parkinson's disease	6.06e-06	0.015	CbGeAlD
Cevimeline—CYP2D6—cerebellum—Parkinson's disease	5.92e-06	0.0146	CbGeAlD
Cevimeline—CYP2D6—brain—Parkinson's disease	4.81e-06	0.0119	CbGeAlD
